Skip to content

Frank Lyons Greenway III, M.D.

NPI 1134456999ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Baton Rouge, LA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Baton Rouge, Louisiana, licensed in LA, with an NPI issued in November 2009. Neurocrine Biosciences, Inc. was the largest of 2 companies reporting payments in 2025, $24,281 in all, mostly consulting fees.

Overview

NPI1134456999
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedNov 15, 2009
Last updated in NPPESNov 15, 2009

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$24,281 · 5 payments from 2 companies
  • 2024$1,761 · 8 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Neurocrine Biosciences, Inc.$24,1864
Novo Nordisk Inc$94.571

What the 2025 payments were for

  • Consulting Fee$24,086 · 3 payments
  • Food and Beverage$194.78 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Baton Rouge

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Louisiana →